These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17786705)

  • 1. Hyperammonemia encephalopathy: an important cause of neurological deterioration following chemotherapy.
    Nott L; Price TJ; Pittman K; Patterson K; Fletcher J
    Leuk Lymphoma; 2007 Sep; 48(9):1702-11. PubMed ID: 17786705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperammonemic encephalopathy after induction chemotherapy for acute lymphoblastic leukemia.
    Jaing TH; Lin JL; Lin YP; Yang SH; Lin JJ; Hsia SH
    J Pediatr Hematol Oncol; 2009 Dec; 31(12):955-6. PubMed ID: 19887962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syndrome of idiopathic hyperammonemia after high-dose chemotherapy: review of nine cases.
    Mitchell RB; Wagner JE; Karp JE; Watson AJ; Brusilow SW; Przepiorka D; Storb R; Santos GW; Burke PJ; Saral R
    Am J Med; 1988 Nov; 85(5):662-7. PubMed ID: 3189370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute hyperammonemic encephalopathy after fluoropyrimidine-based chemotherapy: A case series and review of the literature.
    Mitani S; Kadowaki S; Komori A; Sugiyama K; Narita Y; Taniguchi H; Ura T; Ando M; Sato Y; Yamaura H; Inaba Y; Ishihara M; Tanaka T; Tajika M; Muro K
    Medicine (Baltimore); 2017 Jun; 96(22):e6874. PubMed ID: 28562536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Valproate-induced hyperammonemic encephalopathy. Review of cases in the psychiatric setting].
    Fassi G; Igoa A; Liste OA
    Vertex; 2008; 19(82):371-7. PubMed ID: 19424520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproate-induced hyperammonemic encephalopathy treated by hemodialysis.
    Tsai MF; Chen CY
    Ren Fail; 2008; 30(8):822-4. PubMed ID: 18791959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproate-induced hyperammonemic encephalopathy in a renal transplanted patient.
    Melexopoulou C; Marinaki S; Darema M; Skalioti C; Efthimiou A; Zavos G; Boletis JN
    Ren Fail; 2014 Jul; 36(6):955-6. PubMed ID: 24665854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiopathic hyperammonemic encephalopathy secondary to gemcitabine-cisplatin treatment.
    Verkerk K; Otten HM; Huitema ADR
    Cancer Chemother Pharmacol; 2022 Nov; 90(5):417-419. PubMed ID: 36127544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperammonemic encephalopathy during XELOX regimen. Is it capecitabine or oxaliplatin responsible?
    Di Federico A; Nuvola G; Sisi M; Lenzi B; Nobili E; Campana D
    Anticancer Drugs; 2020 Nov; 31(10):1103-1105. PubMed ID: 32826413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sunitinib-induced hyperammonemic encephalopathy in gastrointestinal stromal tumors.
    Lee NR; Yhim HY; Yim CY; Kwak JY; Song EK
    Ann Pharmacother; 2011 Oct; 45(10):e56. PubMed ID: 21954449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Rare Case of Sunitinib-Induced Hyperammonemic Encephalopathy and Hypothyroidism in Metastatic Renal Cell Carcinoma.
    Pilanc KN; Elbüken F; Ordu Ç; Köksal G; Tekelioğlu MH; Okutur K; Göksel S; Köksal Ü; Akçal T; Tecimer C
    Am J Ther; 2016; 23(2):e583-7. PubMed ID: 24901901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apatinib-induced hyperammonemic encephalopathy.
    Liu Y; Chen X; Gao X; Chen JX; Chen J
    J Oncol Pharm Pract; 2020 Mar; 26(2):465-470. PubMed ID: 31068089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproate-associated hyperammonemic encephalopathy.
    Wadzinski J; Franks R; Roane D; Bayard M
    J Am Board Fam Med; 2007; 20(5):499-502. PubMed ID: 17823470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Valproate-associated hyperammonemic encephalopathy. Report of one case].
    Young P; Finn BC; Alvarez F; Bruetman JE; Trimarchi H
    Rev Med Chil; 2007 Nov; 135(11):1446-9. PubMed ID: 18259656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiopathic hyperammonemia: a frequently lethal complication of bone marrow transplantation.
    Davies SM; Szabo E; Wagner JE; Ramsay NK; Weisdorf DJ
    Bone Marrow Transplant; 1996 Jun; 17(6):1119-25. PubMed ID: 8807124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproic acid induced hyperammonaemic encephalopathy.
    Amanat S; Shahbaz N; Hassan Y
    J Pak Med Assoc; 2013 Jan; 63(1):72-5. PubMed ID: 23865136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperammonemic Encephalopathy due to
    Smith M; Crews JD; Cheek N; Srivastava R; Appachi E
    Pediatrics; 2019 Aug; 144(2):. PubMed ID: 31324704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful use of alternate waste nitrogen agents and hemodialysis in a patient with hyperammonemic coma after heart-lung transplantation.
    Berry GT; Bridges ND; Nathanson KL; Kaplan P; Clancy RR; Lichtenstein GR; Spray TL
    Arch Neurol; 1999 Apr; 56(4):481-4. PubMed ID: 10199339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient hyperammonemia related to chemotherapy with continuous infusion of high-dose 5-fluorouracil.
    Liaw CC; Liaw SJ; Wang CH; Chiu MC; Huang JS
    Anticancer Drugs; 1993 Jun; 4(3):311-5. PubMed ID: 8358058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperammonaemic encephalopathy associated with rituximab-containing chemotherapy.
    Nott L; Price TJ; Pittman K; Patterson K; Young R; Fletcher J
    Intern Med J; 2008 Oct; 38(10):800-3. PubMed ID: 19143880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.